Solara reports highest quarterly profit in three years

Solara Active Pharma Sciences reported Q1 profit of INR 105m, the highest in 12 quarters, with revenues of INR 3,201m. Gross margin improved 960 basis points year-on-year to 54.1%.

The company reduced gross debt by INR 1,433m to INR 6,327m and confirmed progress on demerging its CRAMS and Polymers business, which generated INR 1,080m revenues in FY25.